Description

Learning Objectives

PLACES ARE LIMITED TO 40 PARTICIPANTS.

At the end of these conferences, participant will be able to:

An update on Hormonal Contraception
1.Define absolute and relative contraindications to hormonal contraception .
2.Learn what is new in hormonal contraception.
3.Indicate at what age hormonal contraception may be safely continued until.

Clinical approaches to the management of Abnormal Uterine Bleeding(AUB): Chronic Heavy Menstrual Bleeding (HUB/menorrhagia) pattern.
1.Cite the definition and differential diagnosis of Chronic Abnormal Uterine Bleeding: Chronic Heavy Menstrual Bleeding HMB ((menorrhagia) pattern with no known primary cause .
2.Elaborate clinical approaches to and management strategies for chronic HMB including hormonal and non hormonal approaches, particularly in women with secondary iron deficient anemia with and without fibroids.

An approach to common problems of menopause and perimenopause
1.Formulate an approach to common perimenopausal and monopausal patient complaints and cite general recommendations to council patients with.
2. Define the contraindications to HRT and elaborate on the choices of preparations that can be used including clinical pearls on the advantages and disadvantages of common formulations of HRT.
3. Cite the differential diagnosis of GUS and know what not to miss,
4. Initiate treatment of GUS using non hormonal and hormonal preparations.

Speakers

Moderator : Dr. Jonathan Singerman. Conferences given by Dr. Cleve Ziegler.

Schedule

From 17 h 30 to 17 h 45, Welcome
From 17 h 45 to 18 h 15, Meal
From 18 h 15 to 19 h 15, Conference
From 19 h 15 to 20 h 15, Conference
From 20 h 15 to 20 h 25, Break
From 20 h 25 to 21 h 25, Conference

Conference Venue

This conference will be held at Vago Restaurant, located at 1336 Av. Greene, Westmount, QC H3Z 2B1.

The AMOM recommends that all participants follow the provincial health guidelines related to the COVID-19 pandemic.
Participants acknowledge and accept the health risks that may be associated with in-person participation and understand that they are solely responsible for assessing their own health and taking appropriate safety measures for their situation.

Consent

An attendance list can be sent to the pharmaceutical company after the activity, if requested. By this registration, the general practitioner and/or any other healthcare professional consents to the disclosure of his first and last name to the pharmaceutical company.

The pharmaceutical company agrees not to communicate this information without the consent of the participant.

If you do not want your first and last name disclosed, please contact Ms. Aline Sabbagh at asabbagh@amom.net indicating the activity number.

Recognition of Educational Activities

L’Association des médecins omnipraticiens de Montréal, under the aegis of the FMOQ, recognizes 3.00 hours of professional development activity, of category 1, as required by the professional development regulations of the CMQ. The FMOQ number to retrieve your certificate is 84776.

Educational Subsidy

This activity has received an educational subsidy from Searchlight Pharma inc.